# Modification Of Disease Outcome In COPD

> **NCT00158847** · PHASE4 · TERMINATED · sponsor: **Leiden University Medical Center** · enrollment: 200 (—)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** fluticasone 500 mcg
- **DRUG:** fluticasone 500 mcg + salmeterol 50 mcg

## Key facts

- **NCT ID:** NCT00158847
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-04
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 200 (—)
- **Last updated:** 2006-01-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158847, "Modification Of Disease Outcome In COPD". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00158847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*